Efficacy of Propolis in the Prevention of Oral Mucositis
OM
Determination of the Effectiveness of Propolis in the Prevention of Oral Mucositis in Patients Receiving High Dose Chemotherapy: A Randomized Controlled Trial
1 other identifier
interventional
64
1 country
1
Brief Summary
The study was carried out to determine the efficacy of propolis in the prevention of oral mucositis and gastrointestinal symptoms associated with oral mucositis in patients with leukemia, lymphoma, and myelodysplastic syndrome receiving high-dose chemotherapy and/or hematopoietic stem cell transplantation. 64 patients, 32 in the propolis and 32 in the control group, were involved in the prospective randomized controlled experimental study. While the standard oral care treatment protocol of the clinic was administered to the control group, aqueous propolis extract was applied to the propolis group in addition to the standard oral care treatment protocol.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 22, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 29, 2021
CompletedFirst Submitted
Initial submission to the registry
January 24, 2022
CompletedFirst Posted
Study publicly available on registry
February 22, 2022
CompletedFebruary 22, 2022
February 1, 2022
1.4 years
January 24, 2022
February 20, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Time to onset of oral mucositis
Time to onset of oral mucositis was be evaluated by the World Health Organization Oral Toxicity Scale which record the extent and severity of oral mucositis every day. The World Health Organization Oral Toxicity Scale: range 0 to 4, Grade 0; none, Grade 1; mild, Grade 2; moderate, Grade 3; severe, Grade 4; life threatening
For 21 days from the beginning of the chemotherapy
Incidence of oral mucositis
Incidence of oral mucositis was be evaluated by the World Health Organization Oral Toxicity Scale which record the extent and severity of oral mucositis every day. The World Health Organization Oral Toxicity Scale: range 0 to 4, Grade 0; none, Grade 1; mild, Grade 2; moderate, Grade 3; severe, Grade 4; life threatening
For 21 days from the beginning of the chemotherapy
Severity of oral mucositis
Severity of oral mucositis was be evaluated by the World Health Organization Oral Toxicity Scale which record the extent and severity of oral mucositis every day. The World Health Organization Oral Toxicity Scale: range 0 to 4, Grade 0; none, Grade 1; mild, Grade 2; moderate, Grade 3; severe, Grade 4; life threatening
For 21 days from the beginning of the chemotherapy
The duration of oral mucositis
The duration of oral mucositis was be evaluated by the World Health Organization Oral Toxicity Scale which record the extent and severity of oral mucositis every day. The World Health Organization Oral Toxicity Scale: range 0 to 4, Grade 0; none, Grade 1; mild, Grade 2; moderate, Grade 3; severe, Grade 4; life threatening
From day 1 to day 21 of chemotherapy
Secondary Outcomes (33)
Time to onset of at least grade 2 oral mucositis
From day 1 to day 21 of chemotherapy
Time to onset of dry mouth
From day 1 to day 21 of chemotherapy
Incidence of dry mouth
For 21 days from the beginning of the chemotherapy
Severity of dry mouth
For 21 days from the beginning of the chemotherapy
The duration of dry mouth
For 21 days from the beginning of the chemotherapy
- +28 more secondary outcomes
Study Arms (2)
Aqueous propolis extract
EXPERIMENTALThe individuals in the intervention group were asked to gargle with 5 ml aqueous propolis extract four times a day after meals (morning, noon, evening and night before bedtime) and wait average one minute in the mouth and then spit, in addition to the standard practice of the clinic. According to the standard practice of the clinic, it was performed tanflex (3x1) and/or sodium bicarbonate (1x1) to the patients in the prevention of oral mucositis with the request of the physician. The patients were followed for 21 days. The 21-day period is consistent with the duration of mucositis healing in the literature. Follow-up and evaluation of patients who were discharged early were performed by home visits and made a phone call everyday.
Control
NO INTERVENTIONStandard procedures of the clinic were applied to control group. According to the standard practice of the clinic, it was performed tanflex (3x1) and/or sodium bicarbonate (1x1) to the patients in the prevention of oral mucositis with the request of the physician. Follow-up and evaluation of patients who were discharged early were performed by home visits and made a phone call everyday.
Interventions
The patients gargled 4 times a day after meals and 5 ml each time. Patients were instructed to keep the propolis solution in their mouth for one minute, to touch all structures in the mouth, and not to eat or drink anything orally for one hour after spitting.
Eligibility Criteria
You may qualify if:
- years or older
- Ability to communicate verbally
- Not having a diagnosed psychiatric disease
- Receiving inpatient high dose chemotherapy (diagnosed with leukemia, lymphoma and MDS)
- Hematopoietic Stem Cell Transplantation patients
- Zero OM score according to the World Health Organization Oral Toxicity Scale (WHOOTS)
- Karnofsky Performance Scale (KPS) score of 80 and above
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Karadeniz Technical University
Trabzon, 61000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Seher ÇAKMAK Karadeniz Technical University
Karadeniz Technical University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- No masking
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 24, 2022
First Posted
February 22, 2022
Study Start
May 15, 2019
Primary Completion
September 22, 2020
Study Completion
May 29, 2021
Last Updated
February 22, 2022
Record last verified: 2022-02